Key statistics
On Tuesday, Immunic Inc (10VA:FRA) closed at 1.11, 24.42% above the 52 week low of 0.8905 set on Nov 14, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 1.11 |
---|---|
High | 1.11 |
Low | 1.11 |
Bid | 1.07 |
Offer | 1.09 |
Previous close | 1.08 |
Average volume | 4.62k |
---|---|
Shares outstanding | 90.08m |
Free float | 87.07m |
P/E (TTM) | -- |
Market cap | 110.80m USD |
EPS (TTM) | -1.24 USD |
Data delayed at least 15 minutes, as of Nov 12 2024 07:04 GMT.
More ▼
- EQS-News: Immunic, Inc. Reports Third Quarter 2024 Financial Results and Provides Corporate Update
- EQS-News: Immunic, Inc. to Announce Financial Results for the Third Quarter Ended September 30, 2024, and Provide Corporate Update
- EQS-News: Immunic to Participate in Industry, Scientific and Investor Conferences in November
- EQS-News: Immunic Announces Positive Outcome of Interim Analysis of Phase 3 ENSURE Program of Vidofludimus Calcium in Relapsing Multiple Sclerosis
- EQS-News: Immunic Presents Key Vidofludimus Calcium Data at the 40th Congress of ECTRIMS, Highlighting Its Therapeutic Potential in Multiple Sclerosis
- EQS-News: Immunic Announces First Patient Enrolled in Investigator-Sponsored Phase 2 Clinical Trial of Vidofludimus Calcium in Patients with Post COVID Syndrome
- EQS-News: Immunic to Host Multiple Sclerosis R&D Day and Participate in Scientific and Investor Conferences in September
More ▼